Department of Obstetrics & Gynecology, University of Mississippi Medical Center, 2500 N. State St., Jackson, MS 39216, U.S.A.
Department of Pharmacology & Toxicology, University of Mississippi Medical Center, 2500 N. State St., Jackson, MS 39216, U.S.A.
Clin Sci (Lond). 2018 Oct 29;132(20):2261-2267. doi: 10.1042/CS20180474. Print 2018 Oct 31.
Cysteine-rich angiogenic inducer 61 (CYR61), an angiogenic factor whose expression is decreased in fibroids. The aim of the present study was to determine if CYR61 secretion in smooth muscle cells (SMCs) is regulated by hypoxia and through the endothelin A (ET) receptor. SMCs from fibroids (fSMC) and the adjacent myometrium smooth muscle cells (mSMCs) were extracted from ten women undergoing hysterectomy for uterine fibroids and cultured with or without 1.0 µM of an ET receptor antagonist for 24 h under either normal or hypoxic oxygen conditions. Cellular secretion of endothelin-1 (ET-1) and CYR61 were measured via enzyme linked immunosorbent assay in the cell culture media. SMCs were collected to determine cell proliferation and CYR61 protein expression via Western blot. ET-1 secretion was significantly increased in fSMC and was decreased with blockade of the ET receptor under both normoxia (=0.0004) and hypoxia (=0.008). CYR61 expression was decreased in fSMCs and significantly increased with blockade of the ET receptor under hypoxia (=0.04). Cell proliferation decreased with ET blockade under normoxia (=0.0001) and hypoxia (=0.001). These results suggest that suppression of CYR61 secretion in fSMC is regulated by the ET-1 and that blockade with ET could be considered for a future treatment option.
富含半胱氨酸的血管生成诱导因子 61(CYR61)是一种血管生成因子,其在纤维瘤中的表达降低。本研究旨在确定缺氧是否调节平滑肌细胞(SMCs)中 CYR61 的分泌,以及是否通过内皮素 A(ET)受体进行调节。从因子宫肌瘤接受子宫切除术的 10 名女性中提取纤维瘤(fSMC)和相邻的子宫平滑肌细胞(mSMC),并在正常或缺氧氧条件下,用或不用 1.0 µM 的 ET 受体拮抗剂培养 24 小时。通过酶联免疫吸附试验在细胞培养物中测量内皮素-1(ET-1)和 CYR61 的细胞分泌。通过 Western blot 收集 SMC 以确定细胞增殖和 CYR61 蛋白表达。在正常氧条件下(=0.0004)和缺氧条件下(=0.008),fSMC 中的 ET-1 分泌显着增加,并且阻断 ET 受体后减少。fSMCs 中的 CYR61 表达减少,并且在缺氧条件下阻断 ET 受体后显着增加(=0.04)。在正常氧条件下(=0.0001)和缺氧条件下(=0.001),ET 阻断后细胞增殖减少。这些结果表明,fSMC 中 CYR61 分泌的抑制受 ET-1 调节,并且可以考虑使用 ET 阻断作为未来的治疗选择。